Which genetic determinants should be considered for tacrolimus dose optimization in kidney transplantation? A combined analysis of genes affecting the CYP3A locus

H Bruckmueller, AN Werk, L Renders… - Therapeutic drug …, 2015 - journals.lww.com
Background: Tacrolimus is established as immunosuppressant after kidney transplantation.
Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes significantly to …
被引用次数：67 相关文章

Which genetic determinants should be considered for tacrolimus dose optimization in kidney transplantation?: A combined analysis of genes affecting the CYP3A …

H Bruckmueller, AN Werk… - Therapeutic Drug …, 2015 - portal.findresearcher.sdu.dk
BACKGROUND:: Tacrolimus is established as immunosuppressant after kidney
transplantation. Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes …

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A …

H Bruckmueller, AN Werk, L Renders, T Feldkamp… - 2015 - mediatum.ub.tum.de
Tacrolimus is established as immunosuppressant after kidney transplantation.
Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes significantly to …

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A …

H Bruckmueller, AN Werk, L Renders… - Therapeutic drug …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Tacrolimus is established as immunosuppressant after kidney transplantation.
Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes significantly to …
[PDF] academia.edu

[PDF][PDF] Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the …

H Bruckmueller, AN Werk, L Renders, T Feldkamp… - Ther Drug …, 2015 - academia.edu
Background: Tacrolimus is established as immunosuppressant after kidney transplantation.
Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes significantly to …

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A …

H Bruckmueller, AN Werk, L Renders… - Therapeutic Drug …, 2015 - oceanrep.geomar.de
Background: Tacrolimus is established as immunosuppressant after kidney transplantation.
Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes significantly to …

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A …

H Bruckmueller, AN Werk, L Renders… - Therapeutic Drug …, 2015 - europepmc.org
Background Tacrolimus is established as immunosuppressant after kidney transplantation.
Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes significantly to …

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A …

H Bruckmueller, AN Werk, L Renders… - Therapeutic Drug …, 2015 - oceanrep.geomar.de
Background: Tacrolimus is established as immunosuppressant after kidney transplantation.
Polymorphism of the cytochrome P450 3A5 (CYP3A5) gene contributes significantly to …